In this paper, the synthesis, characterization, and biological evaluation of the novel tetrahydropyrimidines-THPMs are described. THPMs are well-known for wide pharmacological activities such as antimicrobial, anticancer, antiviral, etc. This research includes obtained results of in vitro antimicrobial, anticancer, and α-glucosidase inhibitory activities of the eleven novel THPMs. An antibiotic assessment was done against five bacteria (two Gram-positive and three Gram-negative) and five fungi by determining the minimal inhibitory concentration (MIC), using the broth tube dilution method. The most active antibacterial compounds were , , and , while the best antifungal activity was shown by , , and . The lowest MIC value (0.20 mg/mL) was measured for , , and against the . Moreover, examining the α-glucosidase inhibitory activity revealed the compound as the one with the best activity. The cytotoxic activity was performed on the tumor cell lines (HeLa, K562, and MDA-MB-231) and normal cells (MRC-5). The best antitumor activity was shown by compounds and against HeLa cell lines. The influence on cell cycle and mechanism of action of the most active compounds were examined too. Compound had good antibacterial and anticancer activities, while showed promising antifungal and anticancer activities.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610702 | PMC |
http://dx.doi.org/10.3390/pharmaceutics14102254 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!